期刊文献+

胃癌潜在预后分子标志物的研究进展

Progress in the potential prognosis-related molecular markers of gastric cancer
下载PDF
导出
摘要 胃癌是中国最常见的恶性肿瘤之一,常规手术治疗后患者的预后千差万别。随着分子生物学的发展,胃癌患者的预后判断也有了新的评估方式。我们从免疫相关分子、生物代谢相关分子、肿瘤相关基因、信号转导通路及经典预后分子5个方面对胃癌预后分子标志物进行综述。 Gastric cancer is the most common malignant tumor in China. These patients often face differents prognosis after operation. With the development of molecular biology,we can assess the prognosis of patients with gastric cancer by new methods. This paper reviewed prognosis-related molecular markers of gastric cancer from five aspects,including immune molecules,biological metabolism molecules,tumor-re-lated genes,signal transduction pathways and classic prognostic molecules to assist clinical treatment.
出处 《临床外科杂志》 2016年第11期885-887,共3页 Journal of Clinical Surgery
关键词 胃癌 分子标志物 预后 gastric cancer molecular markers prognosis
  • 相关文献

参考文献2

二级参考文献45

  • 1张建军,刘志明.MMP-9,TIMP-1和IV型胶原在甲状腺癌中的表达及其临床意义[J].中国普通外科杂志,2007,16(1):81-84. 被引量:5
  • 2Christofnri c,New signals from the invasive front[J].Nmum,2006,441(7092):444-450.
  • 3Morgan MR,Thomas GJ,Russell A,et al.The integrin cyoplas-mietail motif EKQ KVDI STDC is suficient to promote tumor cell invasion mediated bymatrixmetallopmteinases (MMP)-2 or MMP-9[J].J Biol Chem,2004,279(25):26533-26539.
  • 4Sharma A,Greenman J.Vascular endothelial growth factor and psychosocial factors in eolorectal cancer[J].Psyehooncology,2008,17(1):66-73.
  • 5张四梅,王玲,孙慧,王宽松.COX-2、MMP-9表达与宫颈癌侵袭转移的关系[J].医学临床研究,2007,24(6):957-959. 被引量:6
  • 6Jemal A, Bray F, Center MM, et al. Global cancer statistics [ J ]. CA Cancer J Clin, 2011, 61 (2): 69-90.
  • 7Coombes RC, Schein PS, Chilvers CE, et al. A randomized trial comparing adjuvant fluorouracil, doxorubicin, and mitomycin with no treatment in operable gastric cancer. International Collaborative Cancer Group [J]. JClinOncol, 1990, 8 (8): 1362 - 1369.
  • 8Bang Y J, Kim YW, Yang HK, et al. Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC) : a phase 3 open - label, randomized controlled trial [ J ]. Lancet, 2012, 379 (9813): 315-321.
  • 9Sasako M, Sakuramoto S, Katai H, et al. Five - year outcomes of a randomized phase m trial comparing adjuvant chemotherapy with S - 1 versus surgery alone in stage Ⅱ or Ⅲ gastric cancer [ J ]. J Clin Oncol,2011, 29 (33): 4387-4393.
  • 10Yannelli JR, Hyatt C, MeConnell S, et al. Growth of tumor - infiltrating lymphoeytes from human solid cancers : summary of a 5 - year experience [ J]. Int J Cancer, 1996, 65 (4) : 413 -421.

共引文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部